	Dual-pathway inhibitory dysfunction in schizophrenia: MEG and behavioral markers for risk stratification. J Psychiatry Neurosci Han Y, Du Y, Xia Y, Hua L, Yao Z, Lu Q. PMID: 42159174 [PubMed - indexed for MEDLINE]
	PSPH and CXCL2 Predict Treatment Response in First-Episode Schizophrenia: a Retrospective Study. Clin Lab Zheng J. PMID: 42159130 [PubMed - indexed for MEDLINE]
	Association of nitric oxide and neurotrophin-3 with cognitive dysfunction in schizophrenia spectrum disorders (SSD): A cross-sectional comparative study. Indian J Psychiatry Periasamy T, Murugiah V, Thankamoni RK, Alexander H, Gurusamy HM, Stanley RRB. PMID: 42158510 [PubMed]
	Stability-Driven Selection of EEG Connectivity Features for Psychosis Classification: A Network-Based Machine Learning Approach. CNS Neurosci Ther Naeim M, Narimani M. PMID: 42157703 [PubMed - indexed for MEDLINE]
	Key Stakeholder Perspectives on Help-Seeking for Psychosis in South and Southeast Asia: A Systematic Mixed-Studies Review and Narrative Synthesis. Int J Ment Health Nurs Aurizki GE, Griffiths R, Renwick L. PMID: 42157637 [PubMed - indexed for MEDLINE]
	Influence of Age and Gender on Short-Term Efficacy, Acceptability and Safety of Antipsychotic Drug Treatment of Adolescents With Schizophrenia: An Individual Patient Data Meta-Analysis. J Am Acad Child Adolesc Psychiatry Storosum BWC, Cohen SE, Tilkema N, Mattila T, van den Brink W, de Haan L, Denys DAJP, Zantvoord JB. PMID: 42155624 [PubMed - as supplied by publisher]
	Plasma metabolomic signature of frailty and risk of late-onset schizophrenia: A prospective cohort study. Schizophr Res Sun L, Bo Y, Li D, Yao P, Sun Z, Cai Q, Chang H, Cheng M, Xue M, Yu Z, Zhu Y, Zhao X. PMID: 42155165 [PubMed - as supplied by publisher]
	Impact of Obstetric Complications in Subjects at Clinical High Risk for Psychosis: A Systematic Review and Meta-Analysis. Acta Psychiatr Scand Baeza I, Tor J, de la Serna E, Sugranyes G, Crispi F, Izquierdo-Renau M, Del Olmo M, Dolz M, García-Rizo C. PMID: 42154536 [PubMed - indexed for MEDLINE]
	Effect of meditation on clinical symptoms and gray matter volume in chronic schizophrenia: a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci Yang M, Ma Y, Huang J, Huang Y, Liu L, Li Z, Cui D. PMID: 42154270 [PubMed - as supplied by publisher]
	Efficacy and safety of Nrf2 activators for schizophrenia: a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci Okazaki M, Sakuma K, Jo H, Nagata Y, Hamanaka S, Nishii Y, Kitajima T, Iwata N, Kishi T. PMID: 42154264 [PubMed - as supplied by publisher]
	Randomized Controlled Trial on the Effects of Metacognitive Training (MCT) in a Sample of Patients With Recent Onset Psychosis: Study of the Impact on the Severity and Dimensions of Delusions, Self-Esteem and Depression. Clin Psychol Psychother Lorente-Rovira E, Luengo A, Barrigón ML, Carrilero RL, Pousa E, Grasa E, Barajas A, Ruiz-Delgado I, Cid J, Gonzalez-Higueras F, Guasp A, Llácer B, Escartí MJ, Carbonell-Asins JA, Moritz S, Sanjuán J, Ochoa S, Metacognition Study Group. PMID: 42152571 [PubMed - indexed for MEDLINE]
	The relationship between ABO blood group and schizophrenia: An analysis based on a Chinese survey. Medicine (Baltimore) Yu K, Bao H, Jiang H, Li D, Chen Z. PMID: 42152393 [PubMed - indexed for MEDLINE]
	Is problematic sexuality a marker for the onset of mental disorders? A cross-sectional study on psychotic-like experiences and sexual behaviour in a non-clinical sample. J Psychiatr Res Doroldi D, Origlia G, Giannini T, Jannini TB, Boldrini T, Del Casale A, Lo Buglio G, Spitoni G, Limoncin E, Pelizza L, Ciocca G. PMID: 42150511 [PubMed - as supplied by publisher]
	Quality of life in schizophrenia: Symptomatic markers of improvement over time. Psychiatr Rehabil J Murphy SM, Flores AT, Sarpal DK, Keshavan MS, Eack SM. PMID: 42149541 [PubMed - as supplied by publisher]
	Editorial Expression of Concern: Schizophrenia diagnosis using innovative EEG feature-level fusion schemes. Phys Eng Sci Med Goshvarpour A, Goshvarpour A. PMID: 42149430 [PubMed - as supplied by publisher]
	Feasibility and Psychometrics of a New Test Battery for Diagnosing Patients With Schizophrenia Spectrum Disorders. Cureus Fichadia PA, Sung H, Kongala S, Weber D, Wang D, Leontieva L. PMID: 42147685 [PubMed]
	Cognitive impairment and associated factors in elderly patients with schizophrenia: a retrospective observational study with phenotype analysis. Front Psychiatry Cai Y, Wu Y, Yao D, Xu Y. PMID: 42147006 [PubMed]
	Directional genetic relationships between obsessive-compulsive disorder and bipolar disorder and schizophrenia. medRxiv Niarchou M, Avila MN, Mahjani B, Buxbaum JD, Mullins N, Grice DE. PMID: 42145598 [PubMed]
	Micronutrient-immune interactions in mood and psychotic disorders: a case-control study of vitamin C, iron, zinc, magnesium, and peripheral blood cell indices. Sci Rep Shahini N, Fotovat N, Bagheri H, Kashani L, Bagheri Y. PMID: 42144425 [PubMed - as supplied by publisher]
	The genetic architecture of autistic traits and negative symptoms in non-affective first-episode psychosis: an exploratory longitudinal study. Eur Neuropsychopharmacol Mezquida G, Perez-Ramos A, Guasch-Capella N, Forte MF, Parellada M, Amoretti S, Serra-Navarro M, Galvañ J, Cuesta MJ, Mané A, la Serna E, Mitjans M, Bioque M, García-Rizo C, Segura AG, Group AP. PMID: 42143913 [PubMed - as supplied by publisher]

Articles 1 - 20 / 68850

Page 1 of 3443



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy